pierluigi giampaolino
University of Naples Federico II
Naples, Italy
Associate Editor
Gynecological Oncology
University of Naples Federico II
Naples, Italy
Associate Editor
Gynecological Oncology
Sapienza University of Rome
Rome, Italy
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Department of Biomedical Sciences, National Research Council (CNR)
Bari, Italy
Associate Editor
Molecular and Cellular Oncology
Hackensack Meridian Health
Montclair, United States
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
University of Naples Federico II
Naples, Italy
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Federal University of Maranhão
São Luís, Brazil
Associate Editor
Genitourinary Oncology
University Hospital Bonn
Bonn, Germany
Associate Editor
Radiation Oncology
University of Turin
Turin, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
VU Medical Center
Amsterdam, Netherlands
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Pisa
Pisa, Italy
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Immunity and Immunotherapy
Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University, Munich
Munich, Germany
Associate Editor
Head and Neck Cancer
University of California, Los Angeles
Los Angeles, United States
Associate Editor
Surgical Oncology
University of Minnesota Health Sciences, University of Minnesota Medical Center
Minneapolis, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Parma
Parma, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Milano-Bicocca
Milan, Italy
Associate Editor
Neuro-Oncology and Neurosurgical Oncology